US 2012/0027815 A1Published application

Use of plasma membrane calcium atpase (pmca) inhibitors to inhibit sperm mobility

OwnerLudwig Neysesinventor

Life of this patent

Estimating the term…

Abstract

The invention relates to the use of plasma membrane calcium ATPase (PMCA) inhibitors for inhibiting sperm mobility to achieve a contraceptive effect. The invention further relates to contraceptive agents comprising one or more PMCA inhibitors.

Claims10

Dependent claims

A method of achieving contraception comprising:

administering a composition comprising an inhibitor that specifically binds to a plasma membrane calcium ATPase 4 (PMCA4) isoform in sperm to effectively suppress sperm mobility.

Dependencies are inferred from the claim text.

Facts

Application: 13/196,655Filed 2 Aug 2011
Priority: DE 10330213.13 Jul 2003
Published: 2 Feb 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/352
Having six-membered rings with one oxygen as the only ring hetero atom: condensed with carbocyclic rings, e.g. methantheline
A61K 31/343
Having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide: condensed with a carbocyclic ring, e.g. coumaran,…
A61P 15/00
Drugs for genital or sexual disorders
A61P 15/16
Drugs for genital or sexual disorders ; Contraceptives: masculine contraceptives

Family

Application10/563,193Continuation · filed 3 Jan 2006
Application13/196,655Continuation
US 2006/0276529 A1Published application
US 8,013,009 B2Related patent
US 2012/0027815 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results